Current Drug Discovery Technologies

ISSN: 1570-1638 - Volume 7, 4 Issues, 2010

Editor-in-Chief:

Vladimir P. Torchilin
Department of Pharmaceutical Science
Center for Pharmaceutical Biotechnology and Nanomedicine
Northeastern University
USA


Regional Editors:

Detlev Boison
RS Dow Neurobiology Laboratories
Portland, OR
USA


Grzegorz Bazylak
Nicolaus Copernicus University
Bydgoszcz
Poland


Martin Braddock
AstraZeneca Research and Development
Leicestershire
UK


Eduardo A. Castro
INIFTA, Theoretical Chemistry Division
La Plata, Buenos Aires
Argentina


Yiyun Cheng
East China Normal University
Shanghai
China


Section Editor:

Section: Environmental Endocrinology

M. Ishido
National Institute for Environmental Studies
Tsukuba
Japan




Editorial Advisory Board:

M. Abdollahi (Tehran University of Medical Sciences, Tehran, Iran)
B.B. Aggarwal (University of Texas MD Anderson Cancer Center, Texas, USA)
C. Ahlberg (Spotfire, Massachusetts, USA)
G.D. Armstrong (University of Calgary, Calgary, Alberta, Canada)
A.M. Aronov (Vertex Pharmaceuticals, Inc., Cambridge, MA, USA)
Y. Audigier (Institute of Molecular Medecine of Rangueil, U858 INSERM, France)
D.L. Banville (AstraZeneca Pharmaceuticals, Wilmington, DE, USA)
J. Bayry (Centre de Recherche des Cordeliers, Paris, France)
S.J. Benkovic (The Pennsylvania State University, Pennsylvania, USA)
C.R. Bramham (University of Bergen, Bergen, Norway)
S. Brase (University of Karlsruhe, Karlsruhe, Germany)
R. Breslow (Columbia University, New York, USA)
M.H. Bronchud (Hospital General of Granollers, Barcelona, Spain)
M.B. Brown (University of Hertfordshire, Herts, UK)
R. Bucala (Yale University School of Medicine, New Haven, CT, USA)
G.L. Challis (University of Warwick, Coventry, UK)
K.K. Chan (The Ohio State University, Ohio, OH, USA)
J.P.F. Chin-Dusting (Baker Heart Research Institute, Melbourne, Australia)
P. Colas (Station Biologique, Place Georges Teissier, Roscoff, France)
R.A. Copeland (GlaxoSmithKline, Collegeville, PA, USA)
R. Cortesi (Ferrara University, Ferrara, Italy)
M. Crawford (Cerep, Inc., Washington, USA)
M. Cristofanilli (The University of Texas, Houston, TX, USA)
J.-V. De Julian Ortiz (Polytechnic University of Valencia, Valencia, Spain)
M.M. De Villiers (University of Wisconsin, Madison, WI, USA)
U.M.G. Döbbeling (University Hospital Zurich, Zurich, Switzerland)
J. Drews (Bear Stearns Health Innoventure, New York, NY, USA)
T.L. Dunckley (Translational Genomics Research Institute, Phoenix, AZ, USA)
E. Estrada (University of Santiago de Compostela, Santiago de Compostela, Spain)
Y. Fang (Corning Inc., Corning, NY, USA)
M. Feher (The Campbell Family Institute for Breast Cancer Research, Toronto, ON, Canada)
W.Y. Feng (Bridge Pharmaceuticals, Beijing, China)
D.R. Flower (University of Oxford, Berkshire, UK)
A. Fura (Bristol-Myers Squibb R&D, Princeton, NJ, USA)
Z.-G. Gao (National Institutes of Health, Bethesda, MD, USA)
G. Gardiner (Yale University, Connecticut, USA)
L. Ghosez (European Institute of Chemistry and Biology, France)
J.C. Glorioso (University of Pittsburgh, Pittsburgh, PA, USA)
B. Gold (National Cancer Institute, Frederick, MD, USA)
J.A. Grosso (Bristol-Myers Squibb R&D, Princeton, NJ, USA)
C.P. Hart (Threshold Pharmaceuticals, Redwood City, CA, USA)
A. Hillisch (Bayer HealthCare AG, Wuppertal, Germany)
A.G. Horti (Johns Hopkins University, Baltimore, Maryland, USA)
K. Houk (University of California, California, USA)
J. Huard (University of Pittsburgh, Pittsburgh, PA, USA)
D.W. Hutmacher (National University of Singapore, Singapore, Singapore)
K. Islam (Arpida, Switzerland)
J.W. Janetka (AstraZeneca R&D Boston, Waltham, MA, USA)
Z.L. Ji (Xiamen University, Fujian, China)
J. Kardos (Hungarian Academy of Sciences, Budapest, Hungary)
K. Kariko (University of Pennsylvania School of Medicine, Philadelphia, PA, USA)
S. Klussmann (Noxxon Pharma AG, Berlin, Germany)
T.A. Kost (GlaxoSmithKline, Research Triangle Park, NC, USA)
W.A. Korfmacher (Schering-Plough Research Institute, Kenilworth, NJ, USA)
M. Komada (Tokyo Institute of Technology, Yokohama, Japan)
M.S. Lajiness (Eli Lilly and Company, Corporate Circle, Indianapolis, IN, USA)
J.M. Lehn (Nobel Laureate) Institut Le Bel, France)
J.-P. Leonetti (Centre de Pharmacologie et Biotechnologie pour la Sante, Montpeillier, France)
C. Lipinski (Pfizer Global R&D, Connecticut, USA)
S.A. Lipton (Burnham Institute for Medical Research, La Jolla, CA, USA)
S. Liu (Schering-Plough Research Institute, Kenilworth, NJ, USA)
E. Lolis (Yale University, New Haven, CT, USA)
K. Maggon (Pharma Biotech R&D, Geneva,Switzerland)
M. Maqueda (University of Granada, Granada, Spain)
C.R. Martin (University of Florida, Gainesville, FL, USA)
N. Maulik (University of Connecticut School of Medicine, Farmington, CT, USA)
T.A. McKinsey (University of Colorado, Denver, CO, USA)
L.K. Minor (Johnson & Johnson Pharmaceutical R&D, Spring House, PA, USA)
L. Mitscher (University of Kansas, Kansas, USA)
S.M. Moghimi (University of Brighton, Brighton, UK)
M. Moloney (University of Oxford, Oxford, UK)
R. Morphy (Organon Laboratories Ltd., Motherwell, UK)
K. Mueller (Hoffman-La Roche Ltd, Switzerland)
D.J. Muller (University of Technology Dresden, Dresden, Germany)
M. Murcko (Vertex Pharm,Cambridge, MA, USA)
J.P. O'Bryan (University of Illinois College of Medicine, Chicago, IL, USA)
T. Ochiya (National Cancer Center Research Institute, Tokyo, Japan)
H. Onishi (Hoshi University, Tokyo, Japan)
E. Paleolog (Imperial College, London, UK)
K.H. Pearce (GlaxoSmithKline, Research Triangle Park, NC, USA)
R.T. Peterson (Massachusetts General Hospital, Charlestown, MA, USA)
Y.G. Pommier (National Institutes of Health, Bethesda, MD, USA)
I.N. Rich (HemoGenix, Inc., Colorado Springs, CO, USA)
D.D. Root (University of North Texas, Denton, TX, USA)
A.P. Russ (University of Oxford, Oxford, UK)
M. Ruvo (University of Naples, Napoli, Italy)
R. Roy (Pharmaqam, Montreal (QC), Canada)
D.K. Sarker (University of Brighton, Brighton, UK)
J. Schlessinger (Yale University, Connecticut, USA)
V. Shanmugasundaram (Pfizer PharmaTherapeutics Research & Development), Groton, CT, USA)
K.B. Sharpless (The Scripps Research Institute (TSRI), California, USA)
M. Simonyi (Institute of Chemistry, Chemical Research Center, Budapest, Hungary)
P.J. Sinko (Rutgers University, Piscataway, NJ, USA)
C.P. Sosa (University of Minnesota, Minneapolis, MN, USA)
M. Spedding (Institute of Research Servier, Suresnes, France)
L. Stewart (deCODE biostructures Inc., Bainbridge Island, WA, USA)
G. Subramanian (Sanofi-aventis, New Jersey, NJ, USA)
K. Sugahara (Hokkaido University Graduate School of Life Science, Hokkaido, Japan)
D.R. Taft (Long Island University, Brooklyn, NY, USA)
P. Talaga (UCB Chemin du Foriest, Braine-l'Alleud, Belgium)
I.V. Tetko (Institute for Bioinformatics, Neuherberg, Germany)
A.A. Toropov (Institute of Geology & Geophysics of Academy Science, Tashkent, Republic Uzbekistan)
F. Torrens (University of Valencia, Valencia, Spain)
G. Trainor (Bristol-Myers Squibb Pharmaceutical, Delaware, USA)
S.M. Turner (KineMed, Inc., Emeryville, CA, USA)
J. Vaidyanathan (University of Medicine and Dentistry of NJ, Newark, NJ, USA)
M.A. Velleca (CGI Pharmaceuticals, Inc., Branford, CT, USA)
F. Vinick (Genzyme, Massachusetts, USA)
M.A. Walker (Bristol-Myers Squibb R&D, Wallingford, CT, USA)
J.J. Wang (Wyeth Pharmaceuticals, Pennsylvania, USA)
P.A. Wender (Stanford University, California, USA)
L.C. Wienkers (Amgen Inc., Seattle, WA, USA)
M.S. Wolfe (Harvard Medical School, Boston, MA, USA)
S. Yamagishi (Kurume University School of Medicine, Kurume, Japan)
A.K. Yudin (University of Toronto, Toronto, Ontario, Canada)
Y. Zhang (Johns Hopkins University, Baltimore, MD, USA)
X. Deng (Emory University School of Medicine, Atlanta, GA, USA)
X.F.S. Zheng (UMDNJ-Robert Wood Johnson Medical School, Piscataway, NJ, USA)
J. Zhou (Department of Pharmacology and Toxicology, University of Texas, Galveston, TX, USA)